Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma

Introduction and Objectives: Autoimmune liver diseases (AILD) are rare causes hepatocellular carcinoma (HCC), and data on the efficacy and tolerability of anti-tumor therapies are scarce. This pan-European study aimed to assess outcomes in AILD-HCC patients treated with tyrosine kinase inhibitors (T...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Louisa Stern, Constantin Schmidt, Lorenz Kocheise, Vincent Joerg, Christian Casar, Aurélie Walter, Joost P.H. Drenth, Maria Papp, Nikolaos K. Gatselis, Kalliopi Zachou, Matthias Pinter, Bernhard Scheiner, Arndt Vogel, Martha M. Kirstein, Fabian Finkelmeier, Oliver Waidmann, Arndt Weinmann, Piotr Milkiewicz, Douglas Thorburn, Neil Halliday, Ana Lleo, Samuel Huber, George N. Dalekos, Ansgar W. Lohse, Henning Wege, Johann von Felden, Kornelius Schulze
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-11-01
Serie:	Annals of Hepatology
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1665268124003284
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!